Cargando…

Insights into the Regulatory Role of m(6)A Epitranscriptome in Glioblastoma

N(6)-methyladenosine (m(6)A) is one of the most widespread and abundant internal messenger RNA modifications found in eukaryotes. Emerging evidence suggests that this modification is strongly linked to the activation and inhibition of cancer pathways and is associated with prognostically significant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Galardi, Silvia, Michienzi, Alessandro, Ciafrè, Silvia Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215676/ https://www.ncbi.nlm.nih.gov/pubmed/32316617 http://dx.doi.org/10.3390/ijms21082816

Ejemplares similares

Long Noncoding RNAs and Cancer Stem Cells: Dangerous Liaisons Managing Cancer
por: Ciafrè, Silvia Anna, et al.
Publicado: (2023)

CPEB1 restrains proliferation of Glioblastoma cells through the regulation of p27(Kip1) mRNA translation
por: Galardi, Silvia, et al.
Publicado: (2016)

The Expression of the Chemokine CXCL14 Correlates with Several Aggressive Aspects of Glioblastoma and Promotes Key Properties of Glioblastoma Cells
por: Fazi, Barbara, et al.
Publicado: (2019)

MEOX2 Regulates the Growth and Survival of Glioblastoma Stem Cells by Modulating Genes of the Glycolytic Pathway and Response to Hypoxia
por: Proserpio, Carla, et al.
Publicado: (2022)

microRNAs and RNA-binding proteins: A complex network of interactions and reciprocal regulations in cancer
por: Ciafrè, Silvia Anna, et al.
Publicado: (2013)

The HIV-1 Tat protein modulates CD4 expression in human T cells through the induction of miR-222
por: Orecchini, Elisa, et al.
Publicado: (2014)

The lncRNA H19 positively affects the tumorigenic properties of glioblastoma cells and contributes to NKD1 repression through the recruitment of EZH2 on its promoter
por: Fazi, Barbara, et al.
Publicado: (2018)

Glioblastoma stem cells express non‐canonical proteins and exclusive mesenchymal‐like or non‐mesenchymal‐like protein signatures
por: Babačić, Haris, et al.
Publicado: (2023)

The RNA editing enzyme ADAR2 restricts L1 mobility
por: Frassinelli, Loredana, et al.
Publicado: (2021)

NF-kB and c-Jun induce the expression of the oncogenic miR-221 and miR-222 in prostate carcinoma and glioblastoma cells
por: Galardi, Silvia, et al.
Publicado: (2011)

ADAR1 restricts LINE-1 retrotransposition
por: Orecchini, Elisa, et al.
Publicado: (2017)

Emerging Roles of N6-Methyladenosine (m6A) Epitranscriptomics in Toxicology
por: Malovic, Emir, et al.
Publicado: (2021)

The m(6)A epitranscriptome on neural development and degeneration
por: Yen, Ya-Ping, et al.
Publicado: (2021)

From A to m(6)A: The Emerging Viral Epitranscriptome
por: Baquero-Perez, Belinda, et al.
Publicado: (2021)

Progress and application of epitranscriptomic m(6)A modification in gastric cancer
por: Xu, Yitian, et al.
Publicado: (2022)

Predict Epitranscriptome Targets and Regulatory Functions of N(6)-Methyladenosine (m(6)A) Writers and Erasers
por: Song, Yiyou, et al.
Publicado: (2019)

Epitranscriptomics: An Additional Regulatory Layer in Plants’ Development and Stress Response
por: Shoaib, Yasira, et al.
Publicado: (2022)

Interplay between the m(6)A Epitranscriptome and Tumor Metabolism: Mechanisms and Therapeutic Implications
por: Fong, Asa Sergei, et al.
Publicado: (2022)

Epitranscriptomics of cancer
por: Tusup, Marina, et al.
Publicado: (2018)

Exon junction complex shapes the m(6)A epitranscriptome
por: Yang, Xin, et al.
Publicado: (2022)

Novel RNA regulatory mechanisms revealed in the epitranscriptome
por: Saletore, Yogesh, et al.
Publicado: (2013)

Impact of the gut microbiota on the m(6)A epitranscriptome of mouse cecum and liver
por: Jabs, Sabrina, et al.
Publicado: (2020)

Interplays of different types of epitranscriptomic mRNA modifications
por: Rengaraj, Praveenkumar, et al.
Publicado: (2021)

Cracking the epitranscriptome
por: Schwartz, Schraga
Publicado: (2016)

Translating the epitranscriptome
por: Hoernes, Thomas Philipp, et al.
Publicado: (2016)

The METTL3-m(6)A Epitranscriptome: Dynamic Regulator of Epithelial Development, Differentiation, and Cancer
por: Maldonado López, Alexandra, et al.
Publicado: (2021)

The Epitranscriptome and Innate Immunity
por: O’Connell, Mary A., et al.
Publicado: (2015)

The mammalian mitochondrial epitranscriptome()
por: Rebelo-Guiomar, Pedro, et al.
Publicado: (2019)

Expanding the epitranscriptome: Dihydrouridine in mRNA
por: Dixit, Sameer, et al.
Publicado: (2022)

New insights into the epitranscriptomic control of pluripotent stem cell fate
por: Che, Young Hyun, et al.
Publicado: (2022)

The Emerging Role of Epitranscriptomics in Cancer: Focus on Urological Tumors
por: Lobo, João, et al.
Publicado: (2018)

Epitranscriptomic Signatures in lncRNAs and Their Possible Roles in Cancer
por: Dinescu, Sorina, et al.
Publicado: (2019)

Lipopolysaccharide Alters the m6A Epitranscriptomic Tagging of RNAs in Cardiac Tissue
por: Han, Ye-Chen, et al.
Publicado: (2021)

Epitranscriptomic Analysis of m6A Methylome After Peripheral Nerve Injury
por: Zhang, Lei, et al.
Publicado: (2021)

m(6)A-Atlas: a comprehensive knowledgebase for unraveling the N(6)-methyladenosine (m(6)A) epitranscriptome
por: Tang, Yujiao, et al.
Publicado: (2020)

Epitranscriptomics: A New Regulatory Mechanism of Brain Development and Function
por: Noack, Florian, et al.
Publicado: (2018)

The Non-N(6)-Methyladenosine Epitranscriptome Patterns and Characteristics of Tumor Microenvironment Infiltration and Mesenchymal Transition in Glioblastoma
por: Xu, Jianye, et al.
Publicado: (2022)

Epitranscriptomics in Normal and Malignant Hematopoiesis
por: Minervini, Crescenzio Francesco, et al.
Publicado: (2020)

Epitranscriptomic influences on development and disease
por: Hsu, Phillip J., et al.
Publicado: (2017)

Recent advances in the plant epitranscriptome
por: Shen, Lisha, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f1cifpc3h51s4m1dn9uf8rr381